M.E. Allison & Co., Inc. Bristol Myers Squibb CO Transaction History
M.E. Allison & Co., Inc.
- $90.7 Billion
- Q4 2024
A detailed history of M.E. Allison & Co., Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, M.E. Allison & Co., Inc. holds 7,410 shares of BMY stock, worth $417,775. This represents 0.46% of its overall portfolio holdings.
Number of Shares
7,410Holding current value
$417,775% of portfolio
0.46%Shares
1 transactions
Others Institutions Holding BMY
# of Institutions
2,551Shares Held
1.46BCall Options Held
31.6MPut Options Held
35M-
Vanguard Group Inc Valley Forge, PA189MShares$10.6 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.95 Billion0.15% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.24 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.39 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA61MShares$3.44 Billion0.61% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $120B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...